持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2013/09/06 | 日証協 | 681,860株 | -0.44% | 255,120株 | +153.6% | 833,756株 | -3.79% | 404,000株 | -48.61% |
2013/08/30 | 日証協 | 684,860株 | +0.15% | 100,600株 | -7.72% | 866,636株 | -1.27% | 786,120株 | +37.89% |
2013/08/23 | 日証協 | 683,860株 | -4.52% | 109,020株 | +55.74% | 877,756株 | -5.62% | 570,120株 | -8.4% |
2013/08/16 | 日証協 | 716,260株 | -3.71% | 70,000株 | -77.61% | 930,036株 | -2.06% | 622,400株 | -22.1% |
2013/08/09 | 日証協 | 743,860株 | +1.12% | 312,600株 | +445.36% | 949,636株 | +0.44% | 799,000株 | -19.54% |
2013/08/02 | 日証協 | 735,610株 | +1.73% | 57,320株 | -31.34% | 945,486株 | +5.47% | 993,000株 | +197.31% |
2013/07/26 | 日証協 | 723,090株 | -1.43% | 83,480株 | -47.5% | 896,486株 | -4.02% | 334,000株 | -52.08% |
2013/07/19 | 日証協 | 733,610株 | -1.21% | 159,000株 | -78.05% | 934,006株 | +1.74% | 697,000株 | -3% |
2013/07/12 | 日証協 | 742,610株 | +28.57% | 724,300株 | +23.39% | 918,006株 | +84.9% | 718,520株 | +644.73% |
2013/07/05 | 日証協 | 577,610株 | -13.35% | 587,000株 | -13.93% | 496,486株 | -5.79% | 96,480株 | +124.35% |
2013/06/28 | 日証協 | 666,610株 | +5.54% | 682,000株 | +31.7% | 527,010株 | +6.04% | 43,004株 | -1.19% |
2013/06/21 | 日証協 | 631,610株 | -1.1% | 517,850株 | -33.21% | 497,006株 | -6.66% | 43,520株 | -54.19% |
2013/06/14 | 日証協 | 638,610株 | -6.03% | 775,300株 | -8.05% | 532,486株 | -2.74% | 95,000株 | +30.14% |
2013/06/07 | 日証協 | 679,610株 | -2.84% | 843,160株 | -12.37% | 547,486株 | +4.39% | 73,000株 | +25.86% |
2013/05/31 | 日証協 | 699,450株 | +11.32% | 962,160株 | +28.24% | 524,486株 | +0.6% | 58,001株 | -53.6% |
2013/05/24 | 日証協 | 628,312株 | +32.43% | 750,300株 | +69.37% | 521,347株 | +12.97% | 125,000株 | +47.06% |
2013/05/17 | 日証協 | 474,450株 | -4.25% | 443,000株 | +5.23% | 461,485株 | +0.64% | 85,000株 | +844.44% |
2013/05/10 | 日証協 | 495,524株 | -1.2% | 421,000株 | -7.06% | 458,559株 | -4.18% | 9,000株 | 0% |
2013/05/02 | 日証協 | 501,524株 | +3.08% | 453,000株 | +62.41% | 478,559株 | -4.4% | 0株 | -100% |
※株式分割は考慮していませんのでご注意ください。
Page Top